Skip to main content
logo
Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
10.92
+0.27 (2.54%)
Sep 22, 2026, 4:00 PM EDT - Market closed

Kazia Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
150772658128
Market Cap Growth
1625.09%2.91%-74.25%-54.61%-54.40%298.54%
Enterprise Value
103552447113
Last Close Price
10.926.2711.4358.00210.00493.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
118.165.854.1139743.178458.3411.23
PB Ratio
3.99-1.29-1.023.304.634.50
P/TBV Ratio
4.94----10.76

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
81.634.342.8035823.576855.409.91

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
0.00-0.05-0.060.150.10-
Net Debt / Equity Ratio
-1.490.480.10-0.29-0.30-0.73
Net Debt / EBITDA Ratio
3.890.300.040.160.245.40
Net Debt / FCF Ratio
4.820.300.110.230.243.03
Asset Turnover
0.040.130.10000.37
Quick Ratio
2.860.320.070.711.103.32
Current Ratio
2.870.350.241.421.403.53
Return on Equity (ROE)
-106.90%--2634.33%-134.97%-89.14%-32.41%
Return on Assets (ROA)
-25.70%-64.28%-71.63%-47.18%-33.76%-9.83%
Return on Capital Employed (ROCE)
-39.20%177.90%675.70%-117.70%-87.00%-12.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-10.16%-193.64%-262.32%-51.49%-29.57%-4.94%
FCF Yield
-6.82%-124.20%-93.86%-38.14%-26.91%-5.34%
Buyback Yield / Dilution
-213.01%-107.81%-43.08%-39.12%-12.57%-61.08%
SEC Filings: 10-K · 10-Q